| Characteristics | % patients (n = 44*) | Global polyuria | p-value** (c2) | |
| or Mean ± SD | Absent (n = 38) | Present (n = 6) | ||
| Location |
|
|
|
|
| Niterói | 36.4 | 87.5 | 12.5 | 1.000 |
| Petrópolis | 63.6 | 85.7 | 14.3 | |
| Age |
|
|
|
|
| Less than 60 years old | 38.6 | 88.2 | 11.8 | 1.000 |
| 60 years or older | 61.4 | 85.2 | 14.8 | |
| Education |
|
|
|
|
| Up to incomplete primary school | 50.0 | 86.4 | 13.6 | 1.000 |
| At least completed primary school | 50.0 | 86.4 | 13.6 | |
| Hesitation |
|
|
|
|
| Absent | 88.6 | 84.6 | 15.4 | 0.801 |
| Present | 11.4 | 100.0 | 0.0 | |
| Slow stream |
|
|
|
|
| Absent | 75.0 | 84.8 | 15.2 | 1.000 |
| Present | 25.0 | 90.9 | 9.1 | |
| Feeling of incomplete bladder emptying |
|
|
|
|
| Absent | 29.5 | 100.0 | 0.0 | 0.220 |
| Present | 70.5 | 80.6 | 19.4 | |
| Post-voiding incontinence |
|
|
|
|
| Absent | 61.4 | 85.2 | 14.8 | 1.000 |
| Present | 38.6 | 88.2 | 11.8 | |
| Pelvic organ prolapse (symptom) |
|
|
|
|
| Absent | 70.5 | 87.1 | 12.9 | 1.000 |
| Present | 29.5 | 84.6 | 15.4 | |
| Anterior vaginal wall prolapse |
|
|
|
|
| Up to stage II | 93.2 | 85.4 | 14.6 | 1.000 |
| Stage III ou IV | 6.8 | 100.0 | 0.0 | |
| Posterior vaginal wall prolapse |
|
|
|
|
| Up to stage II | 97.7 | 86.0 | 14.0 | 1.000 |
| Stage III ou IV | 2.3 | 100.0 | 0.0 | |
| Apical prolapse |
|
|
|
|
| Up to stage II | 97.7 | 86.0 | 14.0 | 1.000 |
| Stage III ou IV | 2.3 | 100.0 | 0.0 | |
| Fecal incontinence |
|
|
|
|
| Absent | 90.9 | 85.0 | 15.0 | 0.945 |
| Present | 9.1 | 100.0 | 0.0 | |
| Constipation (Bristol stool scale) |
|
|
|
|
| Absent | 77.3 | 88.2 | 11.8 | 0.886 |
| Present | 22.7 | 80.0 | 20.0 | |
| Constipation (frequency of bowel movements) |
|
|
|
|
| Absent | 75.0 | 90.9 | 9.1 | 0.310 |
| Present | 25.0 | 72.7 | 27.3 | |
| Recurrent urinary tract infection |
|
|
|
|
| Absent | 81.8 | 91.7 | 8.3 | 0.109 |
| Present | 18.2 | 62.5 | 37.5 | |
| Systemic arterial hypertension |
|
|
|
|
| Absent | 40.9 | 88.9 | 11.1 | 1.000 |
| Present | 59.1 | 84.6 | 15.4 | |
| Diabetes mellitus |
|
|
|
|
| Absent | 63.6 | 85.7 | 14.3 | 1.000 |
| Present | 36.4 | 87.5 | 12.5 | |
| Heart failure |
|
|
|
|
| Absent | 97.7 | 86.0 | 14.0 | 1.000 |
| Present | 2.3 | 100.0 | 0.0 |
|
| Chronic kidney disease |
|
|
|
|
| Absent | 93.2 | 87.8 | 12.2 | 0.874 |
| Present | 6.8 | 66.7 | 33.3 | |
| Chronic venous insufficiency |
|
|
|
|
| Absent | 68.2 | 90.0 | 10.0 | 0.577 |
| Present | 31.8 | 78.6 | 21.4 | |
| Depression/Anxiety |
|
|
|
|
| Absent | 81.8 | 88.9 | 11.1 | 0.641 |
| Present | 18.2 | 75.0 | 25.0 | |
| Number of comorbidities |
|
|
|
|
| Up to 2 comorbidities | 22.7 | 100.0 | 0.0 | 0.365 |
| 3 or more | 77.3 | 82.4 | 17.6 | |
| Antidepressant |
|
|
|
|
| Absent | 77.3 | 88.2 | 11.8 | 0.886 |
| Present | 22.7 | 80.0 | 20.0 | |
| Diuretic |
|
|
|
|
| Absent | 72.7 | 84.4 | 15.6 | 0.893 |
| Present | 27.3 | 91.7 | 8.3 | |
| Calcium channel blocker |
|
|
|
|
| Absent | 75.0 | 81.8 | 18.2 | 0.310 |
| Present | 25.0 | 100.0 | 0.0 | |
| Benzodiazepine |
|
|
|
|
| Absent | 86.4 | 84.2 | 15.8 | 0.684 |
| Present | 13.6 | 100.0 | 0.0 | |
| Angiotensin II receptor blocker |
|
|
|
|
| Absent | 61.4 | 85.2 | 14.8 | 1.000 |
| Present | 38.6 | 88.2 | 11.8 | |
| Beta-blocker |
|
|
|
|
| Absent | 84.1 | 86.5 | 13.5 | 1.000 |
| Present | 15.9 | 85.7 | 14.3 | |
| Hypoglycemic agent |
|
|
|
|
| Absent | 63.6 | 85.7 | 14.3 | 1.000 |
| Present | 36.4 | 87.5 | 12.5 | |
| Insulin |
|
|
|
|
| Absent | 95.5 | 90.5 | 9.5 | 0.010 |
| Present | 4.5 | 0.0 | 100.0 | |
| Angiotensin-converting enzyme inhibitor |
|
|
|
|
| Absent | 90.9 | 85.0 | 15.0 | 0.945 |
| Present | 9.1 | 100.0 | 0.0 | |
| Polypharmacy |
|
|
|
|
| Up to 4 medications | 59.1 | 92.3 | 7.7 | 0.350 |
| 5 or more medications | 40.9 | 77.8 | 22.2 | |
| Body mass index |
|
|
|
|
| Normal | 18.2 | 62.5 | 37.5 | 0.018 |
| Overweight | 31.8 | 78.6 | 21.4 | |
| Obesity | 50.0 | 100.0 | 0.0 | |
| Risk of obstructive sleep apnea |
|
|
|
|
| Low | 34.1 | 80.0 | 20.0 | 0.674 |
| Moderate or high | 65.9 | 89.7 | 10.3 | |
| Stress urinary incontinence |
|
|
|
|
| Absent | 86.4 | 86.8 | 13.2 | 1.000 |
| Present | 13.6 | 83.3 | 16.7 | |
| Urgency urinary incontinence |
|
|
|
|
| Absent | 90.9 | 85.0 | 15.0 | 0.945 |
| Present | 9.1 | 100.0 | 0.0 | |
| Mixed urinary incontinence |
|
|
|
|
| Absent | 27.3 | 91.7 | 8.3 | 0.893 |
| Present | 72.7 | 84.4 | 15.6 | |
| Overactive bladder syndrome |
|
|
|
|
| Absent | 13.6 | 83.3 | 16.7 | 1.000 |
| Present | 86.4 | 86.8 | 13.2 | |
| Quantitative characteristics: |
|
|
|
|
| Caffeine (mg/day)*** | 151.9 ± 65.7 | 153.0 ± 62.5 | 142.0 ± 89.6 | 0.538 |
| Tobacco (packs/year)*** | 4.8 ± 11.8 | 3.7 ± 8.8 | 12.1 ± 23.6 | 0.037 |